MedPath

Promethazine Hydrochloride

Promethazine HCL 25 mg/mL Injection, USP 1 mL Single Dose Ampule

Approved
Approval ID

36c9c162-90af-4f7b-9f56-5d81ed850dbe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2022

Manufacturers
FDA

General Injectables & Vaccines, Inc

DUNS: 108250663

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Promethazine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52584-495
Application NumberANDA083312
Product Classification
M
Marketing Category
C73584
G
Generic Name
Promethazine Hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 5, 2023
FDA Product Classification

INGREDIENTS (1)

Promethazine HydrochlorideActive
Quantity: 25 mg in 1 mL
Code: R61ZEH7I1I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Promethazine Hydrochloride - FDA Drug Approval Details